$26.84+0.23 (+0.86%)
Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, and other pediatric subspecialty care services in the United States.
Pediatrix Medical Group, Inc. in the Healthcare sector is trading at $26.84 with a market capitalization of $2.2B. Wall Street consensus targets $26.33 (6 analysts), implying a -1.9% move over the next 12 months. The stock is currently near its 52-week high of $27.94, remaining 14.4% above its 200-day moving average. On fundamentals, Piotroski 7/9 indicates strong financial quality. The Whystock Score of 95/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $487.78Mβ | $476.20Mβ | $493.77Mβ | $492.88Mβ | $468.84M |
| Gross Profit | $132.47Mβ | $112.96Mβ | $125.98Mβ | $140.35Mβ | $124.73M |
| Operating Income | $65.40Mβ | $46.58Mβ | $54.67Mβ | $74.00Mβ | $63.70M |
| Net Income | $39.84Mβ | $29.57Mβ | $33.68Mβ | $71.71Mβ | $39.26M |
Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, and other pediatric subspecialty care services in the United States. The company offers clinical care to babies born prematurely or with complications wi...